Last updated on May 2020

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments


Brief description of study

This study will develop an algorithm of identifying patients with stage IV NSCLC and Melanoma who could benefit from cancer treatment they receive.

Detailed Study Description

The goal of this research study is to develop an algorithm that predicts the patient's treatment outcome.This algorithm will serve as a tool for physicians when making treatment decisions, specifically for stage IV NSCLC and malignant melanoma patients receiving anti-cancer treatments. The investigators also aim to identify the metabolic pathways that could lead to better therapeutic options. The patients will be given their treatment according to the institute's standard of care. The patients will provide two blood samples and clinical data will be collected from their medical records.

In the first part of the trial, the data obtained from the blood samples and the medical records of the patients will be used to develop the prediction algorithm, and in the second part of the trial, the algorithm will be validated by comparing the objective response rate of the patients to the theoretical response prediction of the algorithm.

Clinical Study Identifier: NCT04056247

Find a site near you

Start Over

Rabin Medical Center

Petah tikva, Israel
6.61miles
  Connect »

Rabin medical center

Petah tikva, Israel
6.61miles
  Connect »

Sourasky Medical Center

Tel Aviv, Israel
9.77miles
  Connect »

Assuta Medical Cetner

Tel Aviv, Israel
9.77miles
  Connect »

Shiba medical center

Tel HaShomer, Israel
9.84miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.